“Qikmo: Vy&Tea Tea Sachets Recalled for Unapproved Sibutramine.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/36090-qikmo-vy-tea-tea-sachets-recalled-for-unapproved-sibutramine. Based on FDA recall #D-0749-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0749-2021%22&limit=1).
The Food and Drug Administration announced on July 14, 2021, that Qikmoov LLC is recalling Vy&Tea because FDA analysis detected the presence of sibutramine. The agency classified the Class I recall as ongoing.
How to tell if you have it
Brand: Qikmoov
Product: Vy&Tea (Vietnamese Labeling with a green leaf and a bird underneath) 15/KLT 45.0G
Quantity: 15 tea sachets per box
Best By Date: 9/2021
Distribution: Nationwide in the USA via the internet; Brazil, Canada, Germany, France, Hong Kong, Italy, Sweden, Switzerland, Thailand, and United Kingdom
The hazard
The product is marketed without an approved New Drug Application or Abbreviated New Drug Application. FDA analysis detected the presence of sibutramine in the tea.
Context
GovInfoNow's records show other recent recalls of similar products include SILINTAN (2025-10-20) and Buy-Herbal Kian Pee Wan Capsules (2026-03-21). Additional FDA findings in 2025-12-15 identified undeclared Sildenafil and Tadalafil in StuffbyNainax MR 7 SUPER 700000 Capsules.
How to tell if you have this one
Check for Vy&Tea tea sachets (15 per box) with Vietnamese labeling featuring a green leaf and bird. Products were sold with a best by date of 9/2021.
Brand
Qikmoov
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for Vy&Tea tea sachets (15 per box) with Vietnamese labeling featuring a green leaf and bird.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Distribution Nationwide in the USA via the internet and to the following countries Brazil, Canada, Germany, France, Hong Kong, Italy, Sweden, Switzerland, Thailand, and United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 28 days after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0749-2021 (July 14, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0749-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.